Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab(®)-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Glioblastoma (GBM) is one of the most aggressive tumors and its 5-year survival is approximately 5%. Fluorescence-guided surgery (FGS) improves the extent of resection and leads to better prognosis. Molecular near-infrared (NIR) imaging appears to outperform conventional FGS, however, novel molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Polikarpov, Dmitry M., Campbell, Douglas H., McRobb, Lucinda S., Wu, Jiehua, Lund, Maria E., Lu, Yanling, Deyev, Sergey M., Davidson, Andrew S., Walsh, Bradley J., Zvyagin, Andrei V., Gillatt, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226459/
https://www.ncbi.nlm.nih.gov/pubmed/32316186
http://dx.doi.org/10.3390/cancers12040984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226459/
https://www.ncbi.nlm.nih.gov/pubmed/32316186
http://dx.doi.org/10.3390/cancers12040984

Ejemplares similares